Zentek Ships First Government of Canada Order of ZenGUARD(TM) Enhanced Air Filters
Zentek’s first federal order validates ZenGUARD filters, though revenue impact remains marginal.

Zentek Ltd. announced the shipment of its first order of ZenGUARD™ Enhanced Air Filters to a federal facility under a Government of Canada standing offer. The agreement, established in August 2026, covers HVAC filtration products for federal facilities in the National Capital Region with a maximum published value of CAD $348,666.84. The contract runs until August 18, 2027, with call-ups issued as requirements arise and no minimum purchase volume guaranteed.
Technical validation highlights a nearly fivefold improvement in aerosol filtration efficiency without increased pressure drop, and an estimated 22% reduction in fan energy consumption compared to standard MERV 13 filters. The product is listed on the Innovative Solutions Canada Pathway to Commercialization source list, enabling direct federal procurement without competitive bidding.
Zentek Ltd. (ZEN) has completed a shipment that marks a routine commercial milestone rather than a market-moving event. The maximum contract value of approximately CAD $349,000 is immaterial to the company's overall valuation and near-term cash flow requirements.
The release confirms the execution of a standing offer announced in August 2026, validating the product's technical performance and regulatory clearance. No new strategic partnerships, pricing changes, or expanded contract scopes were disclosed. While the news aligns with management's stated goal of converting regulatory approvals into recurring commercial orders, the financial impact is expected to be incremental.
Zentek Ltd. (ZEN) operates as a technology development company focused on advanced materials and clean air solutions. Its flagship project is the Albany Graphite Project in Northern Ontario, which targets ultra-high-purity (5N+) graphite for nuclear, defense, and battery markets. The company also maintains secondary platforms, including ZenGUARD™ graphene-enhanced air filtration media and Triera Biosciences aptamer-based diagnostics and CRO services. Zentek has shifted to a capital-discipline strategy, winding down non-core initiatives and focusing on de-risking Albany and commercializing ZenGUARD.